Article

Flap removal may address limitations of epi-LASIK

Results of a pilot study suggest that "flapless epi-LASIK" may offer advantages compared with the standard technique for hastening epithelial healing, visual recovery, and reducing postoperative pain, reported Tom Elmer, MD.

Results of a pilot study suggest that "flapless epi-LASIK" may offer advantages compared with the standard technique for hastening epithelial healing, visual recovery, and reducing postoperative pain, reported Tom Elmer, MD.

Dr. Elmer, Buffalo, New York, compared the two surgeries in a paired eye study including 13 patients.

On postoperative day 1, uncorrected visual acuity (UCVA) was better in the eye with the flap removed in 46% of patients and in the eye with the flap replaced in 31%, while there was no difference between eyes in the remaining 23% of patients. Later during the first week, the difference favoring flap removal widened, and on postoperative day 7, UCVA was better in the eye with the flap removed in 73% of patients.

Epithelial regeneration, assessed as the day when bandage contact lens removal could be performed, occurred on postoperative day 3 or 4 in 54% of eyes with the flap removed compared with only 23% where it was left intact. Assessments of adverse events showed slight advantages for less pain and foreign body sensation if the flap was removed, while there were no differences between eyes in tearing or photophobia.

"Our impressions based on our experience with epi-LASIK were that it offered a slight improvement over conventional PRK for reducing pain in the early postoperative period, but there was no real difference between the procedures in the long-term," Dr. Elmer said. "With an interest in seeing what else we could do to further reduce short-term discomfort and improve visual recovery in a surface ablation procedure, we thought about flapless epi-LASIK.

"Now, we will further investigate this approach by comparing it with standard PRK," Dr. Elmer said.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.